Woodcock's Prophesy Comes True: US FDA ANDA Approvals Decline From Record Levels

 
• By Derrick Gingery

Janet Woodcock’s 2019 prediction that record ANDA approval volumes would not continue is confirmed with the FY 2020 approval total down 21% from the previous year.

3D render of generic pill with granules over white background - Illustration
Complete response letters also were lower than previous fiscal years, in part because of improved communications, the US FDA said. • Source: Shutterstock

More from Generics

More from Biosimilars & Generics